&bgr;-adrenergic receptor polymorphisms
US6498009B1 · kind B1 · utility
7Cited by
3References
42Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 10, 1997 |
| Grant date | Dec 24, 2002 |
| Priority date | — |
| Expiry date | Oct 10, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/156
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention concerns polymorphisms in the &bgr;1- and the &bgr;2-adrenergic receptors. The invention also pertains to methods and molecules for detecting such polymorphisms. The invention further pertains to the use of such molecules and methods in the diagnosis, prognosis, and treatment selection for cardiovascular diseases, obesity, and diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.